CD19 and pancreatic neoplasm: Patients with PDAC and murine pancreatic models revealed that CD19+PD-L1+IL10+IL18R+ Breg subsets produce IL-10 and inhibit antibody-dependent cytotoxicity of T- and NK cells by pancreatic cancer-derived IL-18 (51).